La prognosi dû tumuri dâ prostata dipenni di diversi fatturi, comu lu stadiu dû tumuri, l'età dû malatu e la saluti ginirali, e l'aggressività dî celluli tumurali.
'N ginirali, lu tumuri dâ prostata havi na bona pruognosi, spiciarmenti quannu si scopri 'n tempu.
Lu tassu di supravvivenza a 5 anni pi lu tumuri dâ prostata lucalizzatu (tumuri ca nun si diffunnìu ô di fora dâ prostata) è quasi dû 100%.
È mpurtanti parrari dâ prognosi specifica cu nu prufissiunali dâ saluti, picchì pò variari assai di pirsuna a pirsuna.
Yang X, Wang R, Xu K, Yang F, Chen Y, Zuo Z, Song B: [Knockdown of myeloid cell leukemia 1 gene inhibits the proliferation and promotes apoptosis of prostate cancer cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017, 33 (1): 62-66.
Kubota Y, Ito K, Imai K, Yamanaka H: Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities. Prostate. 2002, 50 (4): 262-9.
Li K, Zhou H, Wang F, Zhao C, Fan C, Wang J: ZBTB38 suppresses prostate cancer cell proliferation and migration via directly promoting DKK1 expression. Cell Death Dis. 2021, 12 (11): 998.
Sun HF, Wang WD, Feng L: Effect of SPAG9 on migration, invasion and prognosis of prostate cancer. Int J Clin Exp Pathol. 2017, 10 (9): 9468-9474.
Xia Q, Li J, Yang Z, Zhang D, Tian J, Gu B: Long non-coding RNA small nucleolar RNA host gene 7 expression level in prostate cancer tissues predicts the prognosis of patients with prostate cancer. Medicine (Baltimore). 2020, 99 (7): e18993.
Dong L, Ding H, Li Y, Xue D, Li Z, Liu Y, Zhang T, Zhou J, Wang P: TRIP13 is a predictor for poor prognosis and regulates cell proliferation, migration and invasion in prostate cancer. Int J Biol Macromol. 2019, 121 (): 200-206.
Rucci N, Angelucci A: Prostate cancer and bone: the elective affinities. Biomed Res Int. 2014, 2014 (): 167035.
['Disclaimer: mèdicu']
['Stu situ web è furnutu sulu pi scopi didattici e nfurmativi e nun è nu cunzigghiu medicu o nu sirvizziu prufissiunali.']
['Li nfurmazzioni furniti nun hannu a èssiri usati pi diagnosticari o curari nu prubblema di saluti o na malatia, e chiddi ca cercanu cunsigghi medici pirsunali hannu a cunsultari nu mèdicu.']
["Pi favuri, nota ca la riti neurali ca pruduci risposti ê dumanni è assai nun pricisa quannu si tratta di cuntinutu numèricu, p'asempiu, lu nùmmaru di pirsuni ca hannu na malatìa spicifica."]
['Cercati sempri lu cunsigghiu dû vostru dutturi o di àutru dutturi qualificatu pi na cunnizzioni medica. Nun trascurati mai lu cunsigghiu medicali prufissiunali o ritarda a circallu pi quarchi cosa ca liggisti nta stu situ.']
['Disclaimer: copyright']
['Lu Digital Millennium Copyright Act di 1998, 17 U.S.C. § 512 (lu DMCA) furnisci nu ricorsu pi li pruprietari di copyright ca cridinu ca lu matiriali ca cumpari nta Internet viula li sò diritti sutta la liggi statunitenzi supra lu copyright. ']
["Si ti pari di bona fidi ca nu cuntinutu o matiriali misu a dispusizzioni ntô cuntattu dû nostru situ o dî nostri sirvizzi viula li tò dritti d'auturi, tu (o lu tò agenti) ci poi mannari na nutìfica addumannànnu la rimozzioni dû cuntinutu o dû matiriali o lu bloccu di l'accessu."]
['Li notificazzioni hannu a èssiri mannati pi scrittu pi posta elittrònica (talìa la sizzioni "Cuntattu" pi l\'indirizzu elittrònicu).']
["Lu DMCA richiedi ca la tò nfurmazzioni di na prisunta violazzioni dô copyright ncludissi li nfurmazzioni siquenti: (1) discrizzioni di l'òpira prutiggiuta dô copyright ca è suggetta â prisunta violazzioni; (2) discrizzioni dû cuntinutu prutiggiutu e nfurmazzioni sufficienti pi pirmittirini di lu truvari; (3) nfurmazzioni di cuntattu pi tìa, cumprisi lu tò nnirizzu, nùmmuru di telefunu e nnirizzu email; (4) na dichjarazzioni di tìa ca hai la bona fidi ca lu cuntinutu di cui ti lamenti nun è auturizzatu dû pruprietariu dô copyright, dû sò agenti o di quarchi liggi; "]
["(5) na dichiarazzioni di tìa, firmata sutta pena di spergiuru, ca li nfurmazzioni dâ notifica sunnu accurati e ca hai l'auturitati di fari valiri li diritti d'auturi ca si dici ca sunnu stati viulati;"]
['e (6) na firma fisica o ilittronica dû pruprietariu dô copyright o di na pirsuna auturizzata a agiri ô sò nnomu.']
['Si nun si cuntènunu tutti li nfurmazzioni di supra, lu trattamentu dâ lagnanza putissi ritardari.']
['Cuntattu']
['Pi favuri mannàtimi na mail cu ogni dumanna/suggerimentu.']
What is prognosis of prostate cancer?
The prognosis of prostate cancer depends on several factors, including the stage of the cancer, the patient's age and overall health, and the aggressiveness of the cancer cells.
In general, prostate cancer has a good prognosis, especially when caught early.
The 5-year survival rate for localized prostate cancer (cancer that has not spread beyond the prostate) is nearly 100%. However, the prognosis worsens as the cancer progresses and spreads to other parts of the body.
It is important to discuss the specific prognosis with a healthcare professional, as it can vary greatly from person to person.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Circa']
['BioMedLib usa computer autumatizzati (algoritmi di machine learning) pi ginirari coppie di dumanni e risposti.']
['Accuminciamu cu 35 miliuna di pubblicazzioni biumediche di PubMed/Medline.']
